Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Annals of Surgical Oncology|September 28, 2024
Optimization of Extended Pelvic Lymph Node Dissection Side for Prostate CancerMasaki Shiota, Masaki Shimbo, Shigehiro Tsukahara, et al.
International Journal of Computer Assisted Radiology and Surgery|April 24, 2026
Deep learning-based renal artery segmentation and angle estimation for registration of endoscopic images and 3D models in robot-assisted partial nephrectomyKeiji Tsukino, Satoshi Kobayashi, Shunsuke Takashima, et al.
BJC Reports|April 24, 2025
Monitoring circulating tumor DNA by recurrent hotspot mutations in bladder cancerShigehiro Tsukahara, Masaki Shiota, Takashi Matsumoto, et al.
Frontiers in Oncology|June 11, 2021
Differential Impact of TGFB1 Variation by Metastatic Status in Androgen-Deprivation Therapy for Prostate CancerMasaki Shiota, Naohiro Fujimoto, Takashi Matsumoto, et al.
Asian Journal of Endoscopic Surgery|January 11, 2024
Salvage robot-assisted radical prostatectomy after carbon ion radiotherapy to the prostateMasaki Shiota, Shigehiro Tsukahara, Dai Takamatsu, et al.
Anticancer Research|November 4, 2021
Prognostic Value of Lower Tract Urinary Symptoms in Clinically Regional Lymph Node-positive Prostate CancerLeandro Blas, Kosuke Ieiri, Masaki Shiota, et al.
Urologic Oncology|July 3, 2021
The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer in a genome-wide association studyShohei Nagakawa, Masaki Shiota, Naohiro Fujimoto, et al.
Anticancer Research|July 20, 2021
Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive Prostate CancerLeandro Blas, Masaki Shiota, Shigetomo Yamada, et al.
Andrologia|November 8, 2021
Clinical impact of HSD3B1 polymorphism by metastatic volume and somatic HSD3B1 alterations in advanced prostate cancerMasaki Shiota, Naohiro Fujimoto, Yohei Sekino, et al.
Cancer Science|October 16, 2020
Gene amplification of YB-1 in castration-resistant prostate cancer in association with aberrant androgen receptor expressionMasaki Shiota, Yohei Sekino, Shigehiro Tsukahara, et al.
Pageof 5